Cart
sales@molnova.com
GSK251
CAS No. 2125968-05-8
GSK251( —— )
Catalog No. M28226 CAS No. 2125968-05-8
GSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 396 | In Stock |
|
| 10MG | 562 | In Stock |
|
| 25MG | 838 | In Stock |
|
| 50MG | 1097 | In Stock |
|
| 100MG | 1488 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK251
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.
-
DescriptionGSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2125968-05-8
-
Formula Weight584.71
-
Molecular FormulaC29H37FN6O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (106.89 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shan X, et al. Analytical techniques for monitoring of toluene and xylene exposure biomarkers hippuric acid and methylhippuric acid in human urine samples. Bioanalysis. 2021 Oct;13(20):1569-1584.
molnova catalog
related products
-
GDC-0326
A potent, selective, orally available PI3Kα inhibitor with Ki of 0.2 nM; displays 133, 20 and 33-fold selectivity over PI3Kβ, PI3Kδ and PI3Kγ, respectively.
-
NVP-BGT226
NVP-BGT226 (BGT226) is a potent, dual PI3K/mTOR inhibitor with a preference for PI3Kα and mTOR.
-
NVP-BKM120
NVP-BKM120 (BKM-120, Buparlisib)?is a potent, selective, orally bioavailable inhibitor of class I PI3K isoforms.
